|
WO2020139019A1
|
|
Lens for prevention, alleviation, or promotive rehabilitation of corneal damage
|
|
KR20200044321A
|
|
Pharmaceutical composition for preventing or treating inflammatory disease
|
|
KR101877722B1
|
|
Pharmaceutical composition and healthfunctional food for preventing or treating of diabetic ulcer
|
|
WO2018080253A1
|
|
Immunity enhancing composition including immune response regulator and cationic liposome, and use of same
|
|
EP3533463A1
|
|
Immune response regulatory substance and vaccine composition containing same
|
|
KR20190021939A
|
|
Varicella-zoster virus vaccine composition comprising cationic liposome and use thereof
|
|
KR20190021938A
|
|
Composition for immune enhancement comprising immune response modulator and cationic liposome and use thereof
|
|
KR20190020209A
|
|
Eye drop composition for ocular health
|
|
KR20190000586A
|
|
Vaccine composition comprising immune response modulator and use thereof
|
|
KR20180047054A
|
|
Immune response modulator and an adjuvant composition comprising the same
|
|
KR20170103330A
|
|
Attenuated Pseudomonas aeruginosa Having Improved Productivity and Safety, and Vaccine Composition Comprising the Same
|
|
RU2677336C2
|
|
Method for obtaining virus-like particles of human papillomavirus
|
|
KR101623344B1
|
|
A container with pharmaceutical powder and solvent
|
|
US2014105868A1
|
|
Method for treating vascular-related disease
|
|
KR20140098999A
|
|
Compositions for reducing or inhibiting the formation of scar comprising BMP-7 and excipients
|
|
KR20140060053A
|
|
Immunity reinforcement agent for influenza vaccine
|
|
KR20130113758A
|
|
E. coli strain for providing two anti-tumor substances
|
|
KR20130103901A
|
|
Pharmaceutical compositions for preventing or treating arteriosclerosis
|
|
KR20120013260A
|
|
Vaccines for Cervical Cancer
|
|
KR20120068647A
|
|
Vaccines capable of inducing enhanced immune responses
|
